Theranostic multimodal potential of magnetic nanoparticles actuated by non-heating low frequency magnetic field in the new-generation nanomedicine
Source abstract
Abstract
The scope of this review involves one of the most promising branches of new-generation biomedicine, namely magnetic nanotheranostics using remote control of functionalized magnetic nanoparticles (f-MNPs) by means of alternating magnetic fields (AMFs). The review is mainly focused on new approach which utilizes non-heating low frequency magnetic fields (LFMFs) for nanomechanical actuation of f-MNPs. This approach is compared to such traditional ones as magnetic resonance imaging (MRI) and radio-frequency (RF) magnetic hyperthermia (MH) which utilize high frequency heating AMF. The innovative principles and specific models of non-thermal magnetomechanical actuation of biostructures by MNP rotational oscillations in LFMF are described. The discussed strategy allows biodistribution monitoring in situ, delivering drugs to target tissues and releasing them with controlled rate, controlling biocatalytic reaction kinetics, inducing malignant cell apoptosis, and more. Optimization of both LFMF and f-MNP parameters may lead to dramatic improvement of treatment efficiency, locality, and selectivity on molecular or cellular levels and allow implementing both drug and drugless, i.e., pure nanomechanical therapy, in particular cancer therapy. The optimal parameters within this approach differ significantly from those used in MH or MRI because of the principal difference in the f-MNP actuation modes. It is shown that specifically designed high gradient, steady magnetic field enables diagnostic and therapeutic LFMF impact localization in the deep tissues within the area ranging from a millimeter to a few centimeters and 3D scanning of affected region, if necessary.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Characterization and Applications of Magnetic Nanoparticles · Nanoparticle-Based Drug Delivery · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Abakumov MA, Nukolova NV, Sokolsky-Papkov M, Shein SA, Sandalova TO, Vishwasrao HM, Grinenko NF, Gubsky IL, Abakumov AM, Kabanov AV, Chekhonin VP (2015) VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor. Nanomedicine: Nanotechnology, Biology, and Medicine 11:825–833. doi: 10.1016/j.nano.2014.12.01110.1016/j.nano.2014.12.011 ↗
2. Ahmed Z, Wieraszko A (2015) Pulsed magnetic stimulation modifies amplitude of action potentials in vitro via ionic channels-dependent mechanism. Bioelectromagnetics 36:386–397. doi: 10.1002/bem.2191710.1002/bem.21917 ↗
3. Al-Ahmady ZS, Chaloin O, Kostarelos K (2014) Monoclonal antibody-targeted, temperature-sensitive liposomes: In vivo tumor chemotherapeutics in combination with mild hyperthermia. J of Control Release 196:332–343. doi: 10.1016/j.jconrel.2014.10.01310.1016/j.jconrel.2014.10.013 ↗
4. Alegre-Cebollada J, Perez-Jimenez R, Kosuri P, Fernandez JM (2010) Single-molecule force spectroscopy approach to enzyme catalysis. J Biol Chem 285:18961–18966. doi: 10.1074/jbc.R109.01193210.1074/jbc.R109.011932 ↗
5. Allia P, Tiberto P (2011) Dynamic effects of dipolar interactions on the magnetic behavior of magnetite nanoparticles. J Nanopart Res 13:7277–7293. doi: 10.1007/s11051-011-0642-210.1007/s11051-011-0642-2 ↗
6. Alphandery E, Chebbi I, Guyot F, Durand-Dubief M (2013) Use of bacterial magnetosomes in the magnetic hyperthermia treatment of tumours: a review. Int J Hyperth 29:801–809. doi: 10.3109/02656736.2013.82152710.3109/02656736.2013.821527 ↗
7. Alshits VI, Darinskaya EV, Koldaeva MV, Petrzhik EA (2008) Magnetoplastic effect in nonmagnetic crystals. In: Hirth JP (ed) Dislocations in Solids, vol 14. Elsevier, Amsterdam, pp 333–437
8. Amorino GP, Fox MH (1996) Effect of hyperthermia on intracellular chloride. J Membr Biol 152:217–222. doi: 10.1007/s00232990009910.1007/s002329900099 ↗
9. Amstad E, Kohlbrecher J, Muller E, Schweizer T, Textor M, Reimhult E (2011) Triggered release from liposomes through magnetic actuation of iron oxide nanoparticle containing membranes. Nano Lett 11:1664–1670. doi: 10.1021/nl200149910.1021/nl2001499 ↗
10. Andrä W, Nowak H (eds) (2007) Magnetism in medicine: a handbook, 2nd edn. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
11. Andrä W, d'Ambly CG, Hergt R, Hilger I, Kaiser WA (1999) Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia. J of Magnetism and Magnetic Materials 194:197–203. doi: 10.1016/s0304-8853(98)00552-610.1016/s0304-8853(98)00552-6 ↗
12. Baetke SC, Lammers T, Kiessling F (2015) Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol 88:20150207. doi: 10.1259/bjr.2015020710.1259/bjr.20150207 ↗
13. Baeza A, Guisasola E, Ruiz-Hernández E, Vallet-Regí M (2012) Magnetically triggered multidrug release by hybrid mesoporous silica nanoparticles. Chem Mater 24:517–524. doi: 10.1021/cm203000u10.1021/cm203000u ↗
14. Baláž P (2008) Mechanochemistry in nanoscience and minerals engineering. Springer, Berlin
15. Banchelli M, Nappini S, Montis C, Bonini M, Canton P, Bertia D, Baglioni P (2014) Magnetic nanoparticle clusters as actuators of ssDNA release. Phys Chem Chem Phys 16:10023–10031. doi: 10.1039/C3CP55470H10.1039/C3CP55470H ↗
16. Bañobre-López M, Piñeiro Y, López-Quintela MA, Rivas J (2014) Magnetic nanoparticles for biomedical applications. In: Bhushan B, Luo D, Schricker SR, Sigmund W, Zauscher S (eds) Handbook of nanomaterials properties. Springer, Berlin, pp 457–49310.1007/978-3-642-31107-9_29 ↗
17. Barbosa N, Agulles-Pedrós L, Daza A, Lozano A (2013) Non-ionizing biological effects and security issues in magnetic resonance. Rev Colomb Radiol 24(4):3790–3795
18. Barnes FS, Greenebaum B (eds) (2007) Handbook of biological effects of electromagnetic fields. Bioengineering and biophysical aspects of electromagnetic fields, Third edn. CRC, Boca Raton
19. Barnes FS, Greenebaum B (2015) The effects of weak magnetic fields on radical pairs. Bioelectromagnetics 36:45–54. doi: 10.1002/bem.2188310.1002/bem.21883 ↗
20. Bauer S, Wiest R, Nolte LP, Reyes M (2013) A survey of MRI-based medical image analysis for brain tumor studies. Phys Med Biol 58:R97–R129. doi: 10.1088/0031-9155/58/13/R9710.1088/0031-9155/58/13/R97 ↗
21. Bichurin M, Petrov V, Srinivasan G (2003) Theory of low-frequency magnetoelectric coupling in magnetostrictive-piezoelectric bilayers. Phys Rev B 68: 054402-(1–13). doi: 10.1103/PhysRevB.68.05440210.1103/PhysRevB.68.054402 ↗
22. Bietenbeck M, Florian A, Faber C, Sechtem U, Yilmaz A (2016) Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now? Int J of Nanomedicine. 11:3191–3203. doi: 10.2147/IJN.S11054210.2147/IJN.S110542 ↗
23. Bingi VN (2011) Fundamentals of electromagnetic biophysics. PysMatLit, Moscow (in Russian)
24. Bingi VN, Savin AV (2003) Effects of weak magnetic fields on biological systems: physical aspects. Physics-Uspekhi 46:259–291. doi: 10.1070/PU2003v046n03ABEH00128310.1070/PU2003v046n03ABEH001283 ↗
25. Binhi VN (2002) Magnetobiology: underlying physical problems. Academic, San Diego
26. Stavroulakis P (ed) (2003) Biological effects of electromagnetic fields. Springer, Berlin
27. Bohara RA, Thorat ND, Pawar SH (2016) Role of functionalization: strategies to explore potential nano-bio applications of magnetic nanoparticles. RSC Adv 6:43989–44012. doi: 10.1039/C6RA02129H10.1039/C6RA02129H ↗
28. Bohara RA, Throat ND, Chaurasia AK, Pawar SH (2015) Cancer cells extinction through magnetic fluid hyperthermia treatment produced by superparamagnetic Co-Zn ferrite nanoparticles. RSC Adv 5:47225–47234. doi: 10.1039/C5RA04553C10.1039/C5RA04553C ↗
29. Bohara RA, Yadav HM, Throat ND, Mali SS, Hong CK, Nanaware SG, Pawar SH (2014) Synthesis of functionalized Co0.5Zn0.5Fe2O4 nanoparticles for biomedical applications. J. of Magnetism and Magnetic Materials 378:397–401. doi: 10.1016/j.jmmm.2014.11.06310.1016/j.jmmm.2014.11.063 ↗
30. Bohnert J, Gräser M, Gleich B, Dössel O (2012) Experimental thresholds of magnetically induced currents via a figure-of-eight coil up to 25 kHz. Biomed Tech 57:185–191. doi: 10.1515/bmt-2012-000710.1515/bmt-2012-0007 ↗
31. Branquinho LC, Marcus S, Carrião MS, Costa AS, Zufelato N, Sousa MH, Miotto R, Ivkov R, Bakuzis AF (2013) Effect of magnetic dipolar interactions on nanoparticle heating efficiency: implications for cancer hyperthermia. Sci Rep 3: 2887-(1–10). doi: 10.1038/srep0288710.1038/srep02887 ↗
32. Brezovich IA (1988) Low frequency hyperthermia: capacitive and ferromagnetic seed methods. Med Phys Monograph 16:82–111
33. Brocklehurst B (2002) Magnetic fields and radical reactions: recent developments and their role in nature. Chem Soc Rev 31(5):301–311. doi: 10.1039/B107250C10.1039/B107250C ↗
34. Buchachenko AL (2014) Magnetic field-dependent molecular and chemical processes in biochemistry, genetics and medicine. Russ Chem Rev 83(1):1–12. doi: 10.1070/RC2014v083n01ABEH00433510.1070/RC2014v083n01ABEH004335 ↗
35. Buchachenko AL (2015) Magneto-biology and medicine. Nova Science, New York
36. Buchachenko AL (2016) Why magnetic and electromagnetic effects in biology are irreproducible and contradictory? Bioelectromagnetics 37:1–13. doi: 10.1002/bem.2194710.1002/bem.21947 ↗
37. Buckway B, Ghandehari H (2016) Nanotheranostics and in-vivo imaging. In: Howard KA et al (eds) Nanomedicine advances in delivery science and technology. Springer, New York, pp 97–129. doi: 10.1007/978-1-4939-3634-2_610.1007/978-1-4939-3634-2_6 ↗
38. Bustamante C, Chemla YR, Forde NR, Izhaky D (2004) Mechanical processes in biochemistry. Annu Rev Biochem 73:705–74810.1146/annurev.biochem.72.121801.161542 ↗
39. Buzug TM, Borgert J (eds) (2012) Magnetic particle imaging. A novel SPIO nanoparticle imaging technique. Springer10.1007/978-3-642-24133-8 ↗
40. Cai X, Yang F, Gu N (2012) Applications of magnetic microbubbles for theranostics. Theranostics 2:103–112. doi: 10.7150/thno.346410.7150/thno.3464 ↗
41. Carslaw HS, Jaeher JC (1959) Conduction of heat in solids. Clarendon, Oxford
42. Cervadoro A, Giverso C, Pande R, Sarangi S, Preziosi L, Wosik J, Brazdeikis A, Decuzzi P (2012) Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. PLoS One 8(2): e57332-(1–14)10.1371/journal.pone.0057332 ↗
43. Chang L, Liu XL, Fan DD, Miao YQ, Zhang H, Ma HP, Liu QY, Ma P, Xue WM, Luo YE, Fan HM (2016) The efficiency of magnetic hyperthermia and in vivo histocompatibility for human-like collagen protein-coated magnetic nanoparticles. Int. J. of Nanomedicine 2016:1175–1185. doi: 10.2147/IJN.S10174110.2147/IJN.S101741 ↗
44. Chen SW, Lai JJ, Chiang CL, Chen CL (2012) Construction of orthogonal synchronized bi-directional field to enhance heating efficiency of magnetic nanoparticles. Rev Sci Instrum 83(6):064701. doi: 10.1063/1.472381410.1063/1.4723814 ↗
45. Chen X, Gambhir SS, Cheon J (2011) Theranostic nanomedicine. Acc Chem Res 44:841–1134. doi: 10.1021/ar200231d10.1021/ar200231d ↗
46. Cheng Z, Zaki AA, Hui JZ, Muzykantov VR, Tsourkas A (2012) Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338:903–910. doi: 10.1126/science.122633810.1126/science.1226338 ↗
47. Chiolerio A, Chiodoni A, Allia P, Martino P (2014) Magnetite and other Fe-oxide nanoparticles. In: Bhushan B, Luo D, Schricker SR, Sigmund W, Zauscher S (eds) Handbook of nanomaterials properties. Springer, Berlin, pp 213–24610.1007/978-3-642-31107-9_34 ↗
48. Cochran DB, Wattamwar PP, Wydra R, Hilt JZ, Anderson KW, Eitel RE, Dziubla TD (2013) Suppressing iron oxide nanoparticle toxicity by vascular targeted antioxidant polymer nanoparticles. Biomaterials 34:9615–9622. doi: 10.1016/j.biomaterials.2013.08.02510.1016/j.biomaterials.2013.08.025 ↗
49. Coffey WT, Kalmykov YP, Waldron JT (2004) The Langevin equation, with applications to stochastic problems in physics, chemistry, and electrical engineering, 2nd edn. World Scientific Publishing Co., Pte. Ltd., Singapore10.1142/5343 ↗
50. Cohen Y, Shoushan SY (2013) Magnetic nanoparticles-based diagnostics and theranostics. Curr Opin Biotechnol 24:1–10. doi: 10.1016/j.copbio.2013.01.00610.1016/j.copbio.2013.01.006 ↗
51. Contreras MF, Sougrat R, Zaher A, Ravasi T, Kosel J (2015) Non-chemotoxic induction of cancer cell death using magnetic nanowires. Int J Nanomedicine 10:2141. doi: 10.2147/IJN.S7708110.2147/IJN.S77081 ↗
52. Creixell M, Bohorquez AC, Torres-Lugo M, Rinaldi C (2011) EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano 5:7124–7129. doi: 10.1021/nn201822b10.1021/nn201822b ↗
53. Cross SE, Jin YS, Rao J, Gimzewski JK (2007) Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol 2:780–783. doi: 10.1038/nnano.2007.38810.1038/nnano.2007.388 ↗
54. CSS K (ed) (2009) Magnetic nanomaterials. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
55. de la Presa P, Luengo Y, Multigner M, Costo R, Morales MP, Rivero G, Hernando A (2012) Study of heating efficiency as a function of concentration, size, and applied field in γ Fe2O3 nanoparticles. J Phys Chem C 116:25602–25610. doi: 10.1021/jp310771p10.1021/jp310771p ↗
56. Demirci U, Khademhosseini A, Langer R, Blander J (2013) Microfluidic technologies for human health. World Scientific, Singapore10.1142/8469 ↗
57. Devadasu VR, Bhardwaj V, Kumar MNVR (2013) Can controversial nanotechnology promise drug delivery. Chem Rev 113(3):1686–1735. doi: 10.1021/cr300047q10.1021/cr300047q ↗
58. Di Corato R, Espinosa A, Lartigue L, Tharaud M, Chat S, Pellegrino T, Ménager C, Gazeau F, Wilhelm C (2014) Magnetic hyperthermia efficiency in the cellular environment for different nanoparticle designs. Biomaterials 35(24):6400–6411. doi: 10.1016/j.biomaterials.2014.04.03610.1016/j.biomaterials.2014.04.036 ↗
59. Doane TL, Burda C (2012) The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem Soc Rev 41:2885–2911. doi: 10.1039/c2cs15260f10.1039/c2cs15260f ↗
60. Dobson J (2008a) Remote control of cellular behaviour with magnetic nanoparticles. Nat Nanotechnol 3:139–143. doi: 10.1038/nnano.2008.3910.1038/nnano.2008.39 ↗
61. Dobson J (2010) Cancer therapy: A twist on tumour targeting. Nat Mater 9:95–96. doi: 10.1038/nmat260410.1038/nmat2604 ↗
62. Dobson J, Cartmell SH, Keramane A, El Haj AJ (2006a) Principles and design of a novel magnetic force mechanical conditioning bioreactor for tissue engineering, stem cell conditioning, and dynamic in vitro screening. IEEE Trans Nanobioscience 5:173–17710.1109/TNB.2006.880823 ↗
63. Dobson J, Cartmell SH, Keramane A, Haj AJE (2006b) Principles and design of a novel magnetic force mechanical conditioning bioreactor for tissue engineering, stem cell conditioning, and dynamic in vitro screening. IEEE Trans Nanobiosci 5:173–177. doi: 10.1109/TNB.2006.88082310.1109/TNB.2006.880823 ↗
64. Dobson J, Keramane A, El Haj AJ (2002) Theory and applications of magnetic force bioreactor. European Cells and Materials 4:42–44
65. Domenech M, Marrero-Berrios I, Torres-Lugo M, Rinaldi C (2013) Lysosomal membrane permeabilization by targeted magnetic nanoparticles in alternating magnetic fields. ACS Nano 7:5091–5101. doi: 10.1021/nn400704810.1021/nn4007048 ↗
66. Dong C, Hu X, Dinu CZ (2016) Current status and perspectives in atomic force microscopy-based identification of cellular transformation. Int J Nanomedicine 11:2107–211810.2147/IJN.S111930 ↗
67. Dong H, Du S, Zheng X, Lyu G, Sun L, Li L, Zhang P, Zhang C, Yan C (2015a) Lanthanide nanoparticles: from design toward bioimaging and therapy. Chem Rev 115:10725–10815. doi: 10.1021/acs.chemrev.5b0009110.1021/acs.chemrev.5b00091 ↗
68. Dong H, Du SR, Zheng XY, Lyu GM, Sun LD, Li LD, Zhang PZ, Zhang C, Yan CH (2015b) Lanthanide nanoparticles: from design toward bioimaging and therapy. Chem Rev 115(19):10725–10815. doi: 10.1021/acs.chemrev.5b0009110.1021/acs.chemrev.5b00091 ↗
69. Dutz S, Hergt R (2014) Magnetic particle hyperthermia—a promising tumour therapy? Nanotechnology 25:452001–452029. doi: 10.1088/0957-4484/25/45/45200110.1088/0957-4484/25/45/452001 ↗
70. Eerenstein W, Mathur ND, Scott JF (2006) Multiferroic and magnetoelectric materials. Nature 442:759–765. doi: 10.1038/nature0502310.1038/nature05023 ↗
71. Environmental and Workplace Health (2015) Limits of human exposure to radiofrequency electromagnetic energy in the frequency range from 3 kHz to 300 GHz. Consumer and Clinical Radiation Protection Bureau Environmental and Radiation Health Sciences Directorate Healthy Environments and Consumer Safety Branch Health Canada. Safety Code 6
72. Environmental Health Criteria 238 (2007) Extremely low frequency (ELF) fields. World Health Organization, Geneva
73. Estelrich J, Sánchez-Martín MJ, Busquets MA (2015) Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomedicine 10:1727–1741. doi: 10.2147/IJN.S7650110.2147/IJN.S76501 ↗
74. Etheridge ML, Hurley KR, Zhang J, Jeon S, Ring HL, Hogan C, Haynes CL, Garwood M, Bischof JC (2014) Accounting for biological aggregation in heating and imaging of magnetic nanoparticles. Technology 2(3):214–228. doi: 10.1142/S233954781450019810.1142/S2339547814500198 ↗
75. Evans E, Heinrich V (2003) Dynamic strength of fluid membranes. C.R Physique 4:265–274. doi: 10.1016/s1631-0705(03)00044-610.1016/s1631-0705(03)00044-6 ↗
76. FCC (2013) Human exposure to radiofrequency electromagnetic fields. Final Rule. ET Docket No. 03-137, FCC 13–39. 78 FR 33634. https://www.federalregister.gov/articles/2013/06/04/2013-12716/human-exposure-to-radiofrequency-electromagnetic-fields . Accessed 16 May 2016
77. Fortin JP, Gazeau F, Wilhelm C (2008) Intracellular heating of living cells through Néel relaxation of magnetic nanoparticles. Eur Biophys J 37:223–228. doi: 10.1007/s00249-007-0197-410.1007/s00249-007-0197-4 ↗
78. Funk RHW, Monsees T, Özkucur N (2009) Electromagnetic effects—from cell biology to medicine. Prog Histochem Cytochem 43(4):177–264. doi: 10.1016/j.proghi.2008.07.00110.1016/j.proghi.2008.07.001 ↗
79. Funkhouser J (2002) Reinventing pharma: theranostic revolution. Curr Drug Discovery 2:17–19
80. Gazeau F, Levy M, Wilhelm C (2008) Optimizing magnetic nanoparticle design for nanothermotherapy. Nanomedicine 3(6):832–84410.2217/17435889.3.6.831 ↗
81. Giordano MA, Gutierrez G, Rinaldi C (2010) Fundamental solutions to the bioheat equation and their application to magnetic fluid hyperthermia. Int J Hyperth 26:475–484. doi: 10.3109/0265673100374964310.3109/02656731003749643 ↗
82. Gleich B (2014) Principles and applications of magnetic particle imaging. Springer10.1007/978-3-658-01961-7 ↗
83. Gleich B, Weizenecker J (2005) Tomographic imaging using the nonlinear response of magnetic particles. Nature 435(30):1114–1217. doi: 10.1038/nature0380810.1038/nature03808 ↗
84. Golovin Y, Morgunov R, Baskakov A (2002) Magnetoresonant softening of solids. Mol Phys 100:1291–1296. doi: 10.1080/0026897011010976310.1080/00268970110109763 ↗
85. Golovin YI (2004) Magnetoplastic effects in solids. Review Physics of the Solid State 46:789–824. doi: 10.1134/1.174495410.1134/1.1744954 ↗
86. Golovin YI, Gribanovskii SL, Golovin DY, Klyachko N, Kabanov A (2014) Single-domain magnetic nanoparticles in an alternating magnetic field as mediators of local deformation of the surrounding macromolecules. Phys Solid State 56:1342–1351. doi: 10.1134/S106378341407014210.1134/S1063783414070142 ↗
87. Golovin YI, Gribanovsky SL, Golovin DY, Klyachko NL, Majouga AG, Master АM, Sokolsky M, Kabanov AV (2015) Towards nanomedicines of the future: remote magneto-mechanical actuation of nanomedicines by alternating magnetic fields. J Control Release 219:43–60. doi: 10.1016/j.jconrel.2015.09.03810.1016/j.jconrel.2015.09.038 ↗
88. Golovin YI, Gribanovsky SL, Golovin DY, Zhigachev AO, Klyachko NL, Majouga AG, Sokolsky M, Kabanov AV (2017) Magnetic nanoparticles as mediators for nanomechanical actuation of biochemical systems by non-heating alternating magnetic field. J Nanopart Res xxxx
89. Golovin YI, Klyachko NL, Golovin DY, Efremova MV, Samodurov AA, Sokolski-Papkov M, Kabanov AV (2013a) A new approach to the control of biochemical reactions in a magnetic nanosuspension using a low-frequency magnetic field. Tech Phys Lett 39:240–243. doi: 10.1134/S106378501303005X10.1134/S106378501303005X ↗
90. Golovin YI, Klyachko NL, Sokolsky-Papkov M, Kabanov AV (2013b) Single-domain magnetic nanoparticles as force generators for the nanomechanical control of biochemical reactions by low frequency magnetic fields. Bulletin of the Russian Academy of Sciences. Physics 77(11):1350–1359. doi: 10.3103/S106287381311013010.3103/S1062873813110130 ↗
91. Golovin YI, Morgunov RB (2001) New type of magnetoplastic effects in linear amorphous polymers. Phys Solid State 43:859–864. doi: 10.1134/1.137136610.1134/1.1371366 ↗
92. Golovin YI, Morgunov RB, Lopatin DV, Baskakov AA (1998) Reversible and irreversible magnetic field-induced changes in the plastic properties of NaCl crystals. Phys Solid State 40:1870–1872. doi: 10.1134/1.113067510.1134/1.1130675 ↗
93. Goodwill PW, Saritas EU, Croft LR, Kim TN, Krishnan KM, Schaffer DV, Conolly SM (2012) X-Space MPI: magnetic nanoparticles for safe medical imaging. Adv Mater 24(28):3870–3877. doi: 10.1002/adma.20120022110.1002/adma.201200221 ↗
94. Gordon RT, Hines JR, Gordon D (1979) Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations. Med Hypotheses 5:83–102. doi: 10.1016/0306-9877(79)90063-X10.1016/0306-9877(79)90063-X ↗
95. Grissom CB (1995) Magnetic field effects in biology: a survey of possible mechanisms with emphasis on radical-pair recombination. Chem Rev 95:3–24. doi: 10.1021/cr00033a00110.1021/cr00033a001 ↗
96. Grzyb T, Mrowczynska L, Szczeszak A, Sniadecki Z, Runowski M, Idzikowski B, Lis S (2015) Synthesis, characterization, and cytotoxicity in human erythrocytes of multifunctional, magnetic, and luminescent nanocrystalline rare earth fluorides. J Nanopart Res 17:399. doi: 10.1007/s11051-015-3191-210.1007/s11051-015-3191-2 ↗
97. Gubin SP (ed) (2009) Magnetic nanoparticles. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. doi: 10.1002/9783527627561.ch110.1002/9783527627561.ch1 ↗
98. Guduru R, Liang P, Runowicz C, Nair M, Atluri V, Khizroev S (2013) Magneto-electric nanoparticles to enable field-controlled high-specificity drug delivery to eradicate ovarian cancer cells. Scientific Reports 3:2953. doi: 10.1038/srep0295310.1038/srep02953 ↗
99. Guidelines ICNIRP (2010) Guidelines for limiting exposure to time-varying electrical and magnetic fields (1 Hz to 100 kHz). Health Phys 99:818–83610.1097/HP.0b013e3181f06c86 ↗
100. Gupta A, Kane RS, Borca-Tasciuc D-A (2010) Local temperature measurement in the vicinity of electromagnetically heated magnetite and gold nanoparticles. J Appl Phys 108:064901(1)–064901(7). doi: 10.1063/1.348560110.1063/1.3485601 ↗